KG (Kestrel Group, Ltd.)
Insider Trading Activity
Every open-market purchase and sale reported by KG officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-12 | Michael Hotchkiss | Director | A | — | — |
| 2026-06-12 | Erik Cohen | Director | A | — | — |
| 2026-06-12 | Joseph Brecher | Director | A | — | — |
| 2026-06-12 | Jeffrey Weissmann | Director | A | — | — |
| 2026-06-12 | STEVEN HAROLD NIGRO | Director | A | — | — |
| 2026-03-20 | Terry Lee Ledbetter | Executive Chairman | MIXED | — | — |
| 2026-03-20 | Patrick J Haveron | President and CFO | MIXED | — | — |
| 2026-03-20 | BRADFORD LUKE LEDBETTER | Chief Executive Officer | MIXED | — | — |
| 2025-09-09 | Jeffrey Weissmann | Director | A | — | — |
| 2025-09-09 | Michael Hotchkiss | Director | A | — | — |
| 2025-09-09 | Erik Cohen | Director | A | — | — |
| 2025-09-09 | Joseph Brecher | Director | A | — | — |
| 2025-09-09 | STEVEN HAROLD NIGRO | Director | A | — | — |
| 2025-05-29 | Joseph Brecher | Director | A | — | — |
| 2025-05-29 | BRADFORD LUKE LEDBETTER | Chief Executive Officer | A | — | — |
| 2025-05-29 | Terry Lee Ledbetter | Executive Chairman | A | — | — |
| 2025-05-29 | STEVEN HAROLD NIGRO | Director | A | — | — |
| 2025-05-29 | Patrick J Haveron | President and CFO | A | — | — |
| 2025-05-29 | LAWRENCE F. METZ | See Remarks | A | — | — |
| 2011-02-02 | PHILIP A INCARNATI | Director | MIXED | — | — |
| 2011-02-02 | EARNEST W DEAVENPORT JR | Director | G | — | — |
| 2011-02-02 | FREDERICK BROUILLETTE JR | Corporate Compliance Officer | MIXED | — | — |
| 2011-02-02 | ELIZABETH M GREETHAM | Director | U | — | — |
| 2011-02-02 | TED G WOOD | Director | U | — | — |
| 2011-02-02 | GREGORY D JORDAN | Director | U | — | — |
| 2011-02-02 | Jeffrey Allen Bailey | Chief Commercial Officer | D | — | — |
| 2011-02-02 | CHARLES MOYER | Director | U | — | — |
| 2011-02-02 | DERACE L SCHAFFER | Director | U | — | — |
| 2011-02-02 | James W Elrod | Chief Legal Officer, A. Sec. | MIXED | — | — |
| 2011-02-02 | BRIAN A MARKISON | President and CEO | MIXED | — | — |
| 2011-02-02 | Kevin S Crutchfield | Director | D | — | — |
| 2011-02-02 | D GREGORY ROOKER | Director | MIXED | — | — |
| 2011-02-02 | ERIC J BRUCE | President, Animal Health | MIXED | — | — |
| 2011-02-02 | Joseph Squicciarino | Chief Financial Officer | MIXED | — | — |
| 2011-02-02 | Eric G Carter | Chief Science Officer | MIXED | — | — |
| 2011-01-20 | FREDERICK BROUILLETTE JR | Corporate Compliance Officer | A | — | — |
| 2011-01-20 | James W Elrod | Chief Legal Officer, A. Sec. | A | — | — |
| 2011-01-20 | Eric G Carter | Chief Science Officer | A | — | — |
| 2011-01-20 | ERIC J BRUCE | President, Animal Health | A | — | — |
| 2011-01-20 | FREDERICK BROUILLETTE JR | Corporate Compliance Officer | M | — | — |
| 2011-01-20 | BRIAN A MARKISON | President and CEO | A | — | — |
| 2011-01-20 | Joseph Squicciarino | Chief Financial Officer | A | — | — |
| 2011-01-20 | James W Elrod | Chief Legal Officer, A. Sec. | M | — | — |
| 2011-01-20 | Eric G Carter | Chief Science Officer | M | — | — |
| 2011-01-20 | ERIC J BRUCE | President, Animal Health | M | — | — |
| 2011-01-20 | Joseph Squicciarino | Chief Financial Officer | M | — | — |
| 2011-01-20 | BRIAN A MARKISON | President and CEO | M | — | — |
| 2011-01-11 | Joseph Squicciarino | Chief Financial Officer | A | — | — |
| 2011-01-11 | Eric G Carter | Chief Science Officer | A | — | — |
| 2011-01-11 | BRIAN A MARKISON | President and CEO | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Executive Chairman | 1,003,074 | — |
| — | Chief Executive Officer | 598,729 | — |
| — | President and CFO | 234,367 | — |
| — | See Remarks | 102,597 | — |
| — | Director | 22,055 | — |
| — | Director | 13,555 | — |
| — | Director | 8,055 | — |
| — | Director | 8,055 | — |
| — | Director | 8,055 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the KG quote page; the site-wide leaderboard is on the insider transactions hub.